Patent Assignment
Reel/Frame 036408/0577
Assignment of Assignor's Interest
Recorded: 2015-08-25
Pages: 8
Assignors
BUKHALID, RAGHIDA
Executed: 2012-06-12
NIELSEN, ULRIK
Executed: 2012-06-12
WERNER, SHANNON
Executed: 2012-06-12
KEARNS, JEFFREY DAVID
Executed: 2012-06-13
Assignee
MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Monoclonal and Oligoclonal Anti-Egfr Antibodies for Use in the Treatment of Tumors Expressing Predominantly High Affinity Egfr Ligands or Tumors Expressing Predominantly Low Affinity Egfr Ligands
Application:
14/833,834 →
Publication:
US 2016/0083800
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.